Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Pulmonary Disease Caused by Opportunist Mycobacteria
NCT00367913Phase 4Completed
- Sponsor
- British Thoracic Society
- Start
- Mar 1995
- Modality
- Microbiome Therapeutics, Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of clarithromycin, ciprofloxacin, mycobacterium vaccae in nontuberculous mycobacterial lung disease, sponsored by British Thoracic Society. Started Mar 1995; status: completed.
02
Drugs
clarithromycinciprofloxacinmycobacterium vaccae
03
Conditions
nontuberculous mycobacterial lung disease
Beyond the preview
Go deeper on NCT00367913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367913.